{"resolution": {"@star-print": "no-star-print", "@resolution-stage": "Agreed-to-Senate", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. RES. 368"}, "official-title": {"#tail": "\n\t", "quote": {"#tail": ".", "#text": "Rare Disease Day"}, "@display": "yes", "#text": "Designating February 28, 2014, as "}, "session": {"#tail": "\n\t\t", "@display": "yes", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "III"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140227", "#text": "February 27, 2014"}, "#tail": "\n\t\t", "@display": "yes", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Brown", "@name-id": "S307"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Barrasso", "@name-id": "S317"}, {"#tail": ", ", "#text": "Mr. Wicker", "@name-id": "S318"}, {"#tail": ", ", "#text": "Mr. Coons", "@name-id": "S337"}, {"#tail": ", ", "#text": "Mr. Bennet", "@name-id": "S330"}, {"#tail": ", ", "#text": "Mr. Whitehouse", "@name-id": "S316"}, {"#tail": ", ", "#text": "Mrs. Feinstein", "@name-id": "S221"}, {"#tail": ", and ", "#text": "Mr. Pryor", "@name-id": "S295"}, {"#tail": ") submitted the following resolution; which was considered and agreed to", "#text": "Ms. Warren", "@name-id": "S366"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "RESOLUTION"}}, "@resolution-type": "senate-resolution", "resolution-body": {"#tail": "\n", "section": {"@section-type": "undesignated-section", "#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Senate", "@entity-id": "0010"}, "#text": "That the "}, "enum": {"#tail": "\n      "}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": {"#tail": ";", "#text": "Rare Disease Day"}, "#text": "designates February 28, 2014, as "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id0eafdbb604d14ac3b0684f34d9e2d5a9", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "recognizes the importance of improving awareness and encouraging accurate and early diagnosis of\n\t\t\t rare diseases and disorders; and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id54ed69507fbc4993b6efb5bf887fffa7", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "supports a national and global commitment to improving access to, and developing new treatments,\n\t\t\t diagnostics, and cures for rare diseases and disorders."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "id2c9c1613cb0d45efad6d1acada5ae2d5", "#text": "\n        "}], "@display-inline": "yes-display-inline", "#text": "\n      ", "@id": "S1"}, "#text": "\n\t\t"}, "@public-private": "public", "#text": "\n\t", "preamble": {"#tail": "\n\t", "whereas": [{"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas a rare disease or disorder is one that affects a small number of patients \u2013 in the United\n\t\t\t States, typically less than 200,000 individuals annually;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas as of the date of approval of this resolution, nearly 7,000 rare diseases affect\n\t\t\t approximately 30,000,000 people in the United States and their families;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas children with rare genetic diseases account for more than half of the population affected\n\t\t\t by rare diseases in the United States;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas great strides have been made in research and treatment for rare diseases as a result of the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Orphan Drug Act", "@value": "Orphan Drug Act"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "public-law", "#text": "Public Law 97\u2013414", "@value": "public-law/97/414"}, "@parsable-cite": "pl/97/414", "#text": "\n          ", "@legal-doc": "public-law"}}}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has made great strides in involving the patient in the\n\t\t\t drug review process as part of its Patient-Focused Drug Development\n\t\t\t program, an initiative that originated in the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Whereas the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Food and Drug Administration\n\t\t\t Safety and Innovation Act", "@value": "Food and Drug Administration Safety and Innovation Act"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "public-law", "#text": "Public Law 112\u2013144", "@value": "public-law/112/144"}, "@parsable-cite": "pl/112/144", "#text": "\n          ", "@legal-doc": "public-law"}}}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in 2013 were orphan\n\t\t\t products intended to treat rare diseases;", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Whereas a third of all treatments approved by the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas lack of  access to effective treatments and difficulty in obtaining reimbursement for\n\t\t\t life-altering, and even life-saving, treatments still exist and remain\n\t\t\t significant challenges for the rare disease community and their families;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas rare diseases and conditions include epidermolysis bullosa, progeria, sickle cell anemia,\n\t\t\t spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD),\n\t\t\t Tay-Sachs, cystic fibrosis, pulmonary fibrosis, many childhood cancers,\n\t\t\t and\n\t\t\t fibrodysplasia\n\t\t\t ossificans progressiva;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas people with rare diseases experience challenges that include difficulty in obtaining\n\t\t\t accurate diagnoses, limited treatment options, and difficulty finding\n\t\t\t physicians or treatment centers with expertise in their diseases;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to facilitate greater collaboration among researchers;", "@entity-type": "federal-body", "#text": "National Institutes of\n\t\t\t Health", "@entity-id": "7529"}, "#text": "Whereas the rare disease community made great strides in 2013, including the passage of the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", which calls\n\t\t\t special attention to rare diseases and directs the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "National Pediatric Research Network Act", "@value": "National Pediatric Research Network Act"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "public-law", "#text": "Public Law 113\u201355", "@value": "public-law/113/55"}, "@parsable-cite": "pl/113/55", "#text": "\n          ", "@legal-doc": "public-law"}}}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " have\n\t\t\t established special offices to advocate for rare disease research and\n\t\t\t treatments;", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}], "#text": "Whereas both the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the National Organization for Rare Disorders, an organization established in 1983 to\n\t\t\t provide services to and advocate on behalf of patients with rare diseases,\n\t\t\t remains a critical public voice for people with rare diseases;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and the National Organization for\n\t\t\t Rare Disorders;", "@entity-type": "act", "#text": "Orphan Drug Act", "@value": "Orphan Drug Act"}, "#text": "Whereas 2013 marked the 30th anniversary of the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the National Organization for Rare Disorders sponsors Rare Disease Day in the United States\n\t\t\t to increase public awareness of rare diseases;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas Rare Disease Day is observed each year on the last day of February;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas Rare Disease Day is a global event, first observed in the United States on February 28,\n\t\t\t 2009, and observed in 60 countries in 2013; and"}, "#text": "\n      "}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "Whereas Rare Disease Day is expected to be observed globally for years to come, providing hope and\n\t\t\t information for rare disease patients around the world: Now, therefore, be\n\t\t\t it"}, "#text": "\n      "}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-02-27"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 SRES 368 ATS: Designating February 28, 2014, as \u201cRare Disease Day\u201d."}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}